COVID-19 Resurgence, KOSDAQ Falls Below 790... Intraday Drop Over 4%

[Asia Economy Reporter Oh Ju-yeon] Amid concerns over the resurgence of the novel coronavirus infection (COVID-19), the KOSDAQ index, which had soared to the 860 level in August, fell below the 790 level. Although the KOSDAQ index hit new highs every day this month, after reaching a peak of 862.76 on the 10th, it plunged below the 800 level in just seven trading days on the 20th, even dropping to 785 during intraday trading.

As of 10:55 a.m., the KOSDAQ index recorded 787.51, a sharp drop of 3.81% compared to the previous trading day. On the 18th, the KOSDAQ index also fell below the 800 level during intraday trading but managed to close at 800.22, barely maintaining the 800 level.

On this day, most of the top market capitalization stocks in the KOSDAQ market declined.

Except for Celltrion Healthcare (1.10%) and Celltrion Pharm (2.92%), all were in a downward trend.

Seegene traded at 222,900 KRW, down 7.51% from the previous trading day, while Alteogen (-1.82%), HL Biopharma (-2.54%), EcoPro BM (-2.65%), Genexine (-1.665%), and KM Healthcare (-5.19%) also declined.

On the other hand, mask-related stocks rose, showing a contrast. Welcron, Lemon, and Mona Lisa increased.

Meanwhile, at 10 a.m., the Korea Disease Control and Prevention Agency Central Disaster and Safety Countermeasures Headquarters (CDSCH) announced that as of midnight on the 20th, 288 new domestic COVID-19 cases were confirmed in one day. The cumulative number of confirmed cases rose to 16,346. It has been in the triple digits for a week straight.

This content was produced with the assistance of AI translation services.